Jacob Gottlieb Moved On To Altium
Jacob Gottlieb was Visium Asset Management’s founder and CIO. He is now the head of Altium Capital. He won a school stock picking contest when he was a teenager. His academic and professional success was due to his work ethic and parent’s support. He graduated Magna Cum Laude and received his Bachelor of Arts in Economic at Brown University. He attended NYU Medical School to earn his M.D. He went to St. Vincent’s Hospital to complete a medical internship. He decided not to work in medicine, but instead, pursue a financial career.
Jacob Gottlieb became a buy-side analyst for Sanford C. Bernstein & Co. In 2001, he received his Certified Financial Analyst designation. He left Sanford to become Merlin Biomed Group’s healthcare portfolio manager. He then went to Balyasny Asset Management and became one of the firm’s top earners. In 2005, he started Visium with colleagues and family members. He raised $300 million in seed capital. He oversaw the recruitment and led the portfolio managers to become very successful. Visium was worth $8 billion and had 170 employees working at offices in New York, San Francisco, and London. In 2016, the SEC and U.S. Attorney’s Office charged three Visium employees with insider trading and securities mismarking. These charges led to a decrease in employees and capital which forced Gottlieb to close down Visium. He completed his work at the fund this year.
Jacob Gottlieb has moved on to Altium. He has a strong professional network and a great reputation as a healthcare investor. He opened an office in New York City that he shared with Bay City Capital and Iguana Healthcare Partners. Altium’s first investments were in Sellas Life Sciences and Oramed Pharmaceuticals Inc. The two companies are pharmaceutical companies that have products in the final stages of FDA approval. The products might have a significant impact on the medical and pharmaceutical fields.